Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Other Operating Expenses: 2014-2024

Historic Other Operating Expenses for Theravance Biopharma (TBPH) over the last 6 years, with Dec 2024 value amounting to $4.5 million.

  • Theravance Biopharma's Other Operating Expenses was N/A to $1.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.0 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is N/A change from last year.
  • Per Theravance Biopharma's latest filing, its Other Operating Expenses stood at $4.5 million for FY2024, which was up 531.19% from $715,000 recorded in FY2018.
  • Theravance Biopharma's 5-year Other Operating Expenses high stood at $4.5 million for FY2024, and its period low was $4.5 million during FY2024.
  • Moreover, its 1-year median value for Other Operating Expenses was $4.5 million (2024), whereas its average is $4.5 million.